While ECT is generally a safe and effective treatment, certain medical conditions require extra caution. This is because ECT can temporarily affect various body systems, such as the cardiovascular and nervous systems. For some patients, these effects pose a higher risk. The American Psychiatric Association Task Force recognizes no absolute contraindications to ECT; the conditions below are relative contraindications that raise risk and call for optimization and a deliberate risk-benefit decision rather than automatic exclusion.
Cardiovascular Conditions: Patients with unstable heart conditions, like those who have recently had a heart attack (myocardial infarction), are at a greater risk during ECT. Similarly, individuals with severe arrhythmias (irregular heartbeats) or aortic aneurysms (a dangerous bulging in the wall of the aorta, the main artery leaving the heart) need a thorough evaluation before undergoing ECT. The electrical stimulation involved in ECT can sometimes lead to changes in heart rate and blood pressure, which could be dangerous for patients with these conditions.
Neurological Concerns: ECT may pose additional risks for patients with increased intracranial pressure (pressure inside the skull) or those who have recently suffered a stroke. The procedure could potentially increase intracranial pressure further or aggravate a recent stroke. Therefore, careful consideration is required to weigh the potential benefits of ECT against these risks, particularly for patients with complex medical histories or multiple health issues.
Other Conditions That Raise Risk: Pheochromocytoma is a serious concern because the sympathetic surge of the seizure can precipitate a catecholamine crisis. An unstable intracranial aneurysm or vascular malformation may rupture with the abrupt rise in blood pressure, and a space-occupying intracranial lesion is the classic high-risk neurological condition because of the transient increase in cerebral blood flow and intracranial pressure. Severe pulmonary disease, such as poorly controlled asthma or COPD, and American Society of Anesthesiologists physical status 4 or 5 also raise the risk of the brief anesthetic. Unstable angina, decompensated heart failure, and severe valvular disease belong with the cardiovascular conditions above.
Pacemakers and Implantable Defibrillators: A cardiac implantable electronic device is not a contraindication. The ECT current is largely confined to the head, but the muscle potentials from succinylcholine fasciculations and from the seizure itself can be sensed by the device. A pacemaker may interpret them as intrinsic beats and withhold pacing, so a pacemaker-dependent patient is usually converted to an asynchronous mode with a magnet or reprogramming for the treatment, and an implantable cardioverter-defibrillator has its tachyarrhythmia therapies suspended with a magnet or programmer during the stimulus and seizure, with an external defibrillator at hand and the device re-enabled and checked afterward. Device interrogation before the first treatment and after the course is standard.
Pregnancy: ECT has been used safely in all three trimesters and is often preferable to prolonged exposure to high-dose psychotropic medication. Anesthetic management follows the usual pregnancy principles: aspiration prophylaxis with a nonparticulate antacid, left uterine displacement after about 20 weeks, a low threshold for tracheal intubation in later pregnancy, fetal heart rate documentation before and after the treatment (continuous monitoring once the fetus is viable and an obstetric team is available), and obstetric consultation. Glycopyrrolate is the preferred anticholinergic because it crosses the placenta poorly, and hyperventilation is used sparingly because hypocapnia reduces uterine blood flow.
Deciding whether a patient is suitable for ECT involves evaluating their overall health, specific medical conditions, and the severity of their psychiatric symptoms. It's important to balance the potential benefits of ECT in alleviating severe symptoms against any increased risks posed by these underlying medical conditions.
| Condition | Why it raises risk |
|---|---|
| Recent myocardial infarction | Unstable cardiac status; the electrical stimulation can change heart rate and blood pressure |
| Severe arrhythmias | Irregular heartbeats warrant thorough evaluation before ECT given the cardiovascular response to stimulation |
| Aortic aneurysm | Bulging of the aortic wall; needs thorough evaluation given the blood pressure changes ECT can produce |
| Increased intracranial pressure | The procedure could raise pressure inside the skull further |
| Recent stroke | The procedure could aggravate a recent stroke |
| Intracranial mass | A space-occupying lesion is the classic high-risk neurological condition; cerebral blood flow and intracranial pressure rise transiently with the seizure |
| Unstable intracranial aneurysm or vascular malformation | The abrupt blood pressure rise of the sympathetic phase can cause rupture |
| Pheochromocytoma | The seizure's sympathetic surge can precipitate a catecholamine crisis |
| Severe pulmonary disease; ASA 4 or 5 | Raise the risk of the brief general anesthetic itself |
| Pacemaker or ICD | Not a contraindication; muscle potentials can be sensed, so asynchronous pacing if dependent and ICD therapies suspended for the stimulus and seizure |
| Pregnancy | Not a contraindication; aspiration prophylaxis, left uterine displacement after about 20 weeks, fetal heart rate monitoring, obstetric consultation |
